EP Patent

EP2389927A1 — Pharmaceutical formulations of rasagiline

Assigned to Abdi Ibrahim Ilac Sanayi Ve Ticaret AS · Expires 2011-11-30 · 14y expired

What this patent protects

This invention is related to dissolving of rasagiline in a solvent or mixtures thereof, and treating the drug solution onto pharmaceutical material to provide the content uniformity.

USPTO Abstract

This invention is related to dissolving of rasagiline in a solvent or mixtures thereof, and treating the drug solution onto pharmaceutical material to provide the content uniformity.

Drugs covered by this patent

Patent Metadata

Patent number
EP2389927A1
Jurisdiction
EP
Classification
—
Expires
2011-11-30
Drug substance claim
No
Drug product claim
No
Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.